Zobrazeno 1 - 10
of 173
pro vyhledávání: '"K. Yoshidome"'
Publikováno v:
AIP Advances, Vol 13, Iss 2, Pp 025120-025120-4 (2023)
Metallic ribbons of different compositions were prepared using a single-roller melt-spinning method. The (Fe0.8Co0.2)83B11P4Si2 alloy without Cr showed both high saturation magnetic flux (Bs) of 1.78 T and high corrosion resistance, with a corrosion
Externí odkaz:
https://doaj.org/article/998306b6198d4b8ca2d6f7d7c176dec8
Publikováno v:
AIP Advances, Vol 12, Iss 3, Pp 035312-035312-5 (2022)
The possibility of the powderization of precursor with a single amorphous phase was investigated in FeBNbP nanocrystalline alloy particles and FeBNbPSi nanocrystalline alloy powders. Fe90−xBxNb7P3 (x=9, 10), Fe79.5B9.5Nb7P3Si1 and Fe82−x B9Nb6P3S
Externí odkaz:
https://doaj.org/article/7862016052fb4446b9bfce32613c8d9d
Autor:
A. Hasegawa, H. Kumaoka, Y. Kajiura, M. Hosono, K. Yoshidome, S. Mori, K. Horino, H. Matsumoto
Publikováno v:
AIP Advances, Vol 10, Iss 1, Pp 015241-015241-4 (2020)
The influence of P content on amorphous forming ability and the magnetic characteristics were investigated in the FeBNbP nanocrystalline alloys using metallic ribbons. The Fe84-xB9Nb7Px(x=0-3) and Fe80B10Nb7P3 nanocrystalline alloy metallic ribbons p
Externí odkaz:
https://doaj.org/article/20edf42654b04f2fa48b569ed3796e1e
Autor:
Tomio Nakayama, Takashi Watanabe, Hideo Inaji, Mina Takahashi, Yoshinori Ito, Shozo Ohsumi, K Yoshidome, Kazuhiko Nakagami, K Yonemori, Yutaka Tokuda, Yasuo Ohashi, Y Yamaguchi, Shintaro Takao
Publikováno v:
Cancer Research. 79:P1-13
Background: Two randomized controlled trials comparing the efficacy of oral tegafur-uracil (UFT) (2 years) with that of classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) (6 courses) were conducted in patients with resected early brea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1b488d7585fc1517de1eb9cbfbf6396
https://doi.org/10.1158/1538-7445.sabcs18-p1-13-09
https://doi.org/10.1158/1538-7445.sabcs18-p1-13-09
Autor:
M Yamaguchi, T Nakayama, T Yoshinami, M Ikeda, M Iwamoto, Y Komoike, T Takashima, J Tsurutani, K Yoshidome, T Yamada, S Morita, N Masuda
Publikováno v:
Cancer Research. 78:OT2-06
Background: The combination therapy of Bevacizumab (B) and Paclitaxel (P) has proved to prolong progression free survival (PFS) in E2100 and MERiDiAN study for advanced and metastatic breast cancer(AMBC). Because of its longer PFS, developing optimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fa97f6fc365096ceb151d0452fd1110
https://doi.org/10.1158/1538-7445.sabcs17-ot2-06-02
https://doi.org/10.1158/1538-7445.sabcs17-ot2-06-02
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Masahiko Tsujimoto, S. Takayama, M. Tani, K. Yoshidome, Masaaki Matsuura, Mitsuru Takahashi, Takayuki Kinoshita, Nobuaki Sato, Takashi Ishikawa, M. Itakura, Kenzo Shimazu, K. Kuraoka, Shinzaburo Noguchi, Y. Ohi, Hitoshi Tsuda, K. Kaneko, Tomo Osako, D. Yotsumoto, Futoshi Akiyama, Seigo Nakamura
Publikováno v:
Annals of Oncology. 31:S314-S315
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de3bcdfdf0ca768dcade95d98722e8fe
https://doi.org/10.1016/j.annonc.2020.08.302
https://doi.org/10.1016/j.annonc.2020.08.302
Autor:
B-W Park, Reiki Nishimura, Shinji Ohno, Shintaro Takao, S-A Im, H. Iwata, M. Toi, S-B Kim, SJ Lee, Kenjiro Aogi, Shoichiro Ohtani, Yasuhiro Yanagita, K Yoshidome, Yasuo Ohashi, Y-H Im, Noriyuki Masuda
Publikováno v:
Cancer Research. 73:P3-12
Background Patients (pts) without pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) have a poor prognosis compared with pts achieving a pCR with NAC. It is not clear whether further systemic chemotherapy is beneficial for pts wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6b8da0025feb1e38149bd471e65bb53
https://doi.org/10.1158/0008-5472.sabcs13-p3-12-03
https://doi.org/10.1158/0008-5472.sabcs13-p3-12-03
Autor:
Noriyuki Masuda, Seigo Nakamura, Hiroyuki Takei, Junichi Kurebayashi, H Sonoo, S Masuda, Seung Jin Kim, Hideo Inaji, Masahiko Tsujimoto, Fumine Tsukamoto, K. Yoshidome, Futoshi Akiyama, Shinzaburo Noguchi
Publikováno v:
Cancer Research. 72:P2-10
Background: We have previously reported on the Cell Cycle Profiling (C2P) assay for determining the specific activity (SA, activity/expression) of cyclin-dependent kinases (CDKs). The C2P-risk score (C2P-RS) based on CDK1 and CDK2 SAs was significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22ccb5ec8d368eeff4ae3661578a102e
https://doi.org/10.1158/0008-5472.sabcs12-p2-10-18
https://doi.org/10.1158/0008-5472.sabcs12-p2-10-18